Cargando…

Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines

Genome-wide association studies (GWAS) have contributed to our understanding of glioma susceptibility. To date, 25 risk loci for development of any of the glioma subtypes are known. However, GWAS studies reveal little about the molecular processes that lead to increased risk, especially for non-codi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenbaum, Adam, Dahlin, Anna M., Andersson, Ulrika, Björkblom, Benny, Wu, Wendy Yi-Ying, Hedman, Håkan, Wibom, Carl, Melin, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130147/
https://www.ncbi.nlm.nih.gov/pubmed/37185361
http://dx.doi.org/10.1038/s41598-023-33923-4
_version_ 1785030907029094400
author Rosenbaum, Adam
Dahlin, Anna M.
Andersson, Ulrika
Björkblom, Benny
Wu, Wendy Yi-Ying
Hedman, Håkan
Wibom, Carl
Melin, Beatrice
author_facet Rosenbaum, Adam
Dahlin, Anna M.
Andersson, Ulrika
Björkblom, Benny
Wu, Wendy Yi-Ying
Hedman, Håkan
Wibom, Carl
Melin, Beatrice
author_sort Rosenbaum, Adam
collection PubMed
description Genome-wide association studies (GWAS) have contributed to our understanding of glioma susceptibility. To date, 25 risk loci for development of any of the glioma subtypes are known. However, GWAS studies reveal little about the molecular processes that lead to increased risk, especially for non-coding single nucleotide polymorphisms (SNP). A particular SNP in intron 2 of LRIG1, rs11706832, has been shown to increase the susceptibility for IDH1 mutated low-grade gliomas (LGG). Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is important in cancer development as it negatively regulates the epidermal growth factor receptor (EGFR); however, the mechanism responsible for this particular risk SNP and its potential effect on LRIG1 are not known. Using CRISPR-CAS9, we edited rs11706832 in HEK293T cells. Four HEK293T clones with the risk allele were compared to four clones with the non-risk allele for LRIG1 and SLC25A26 gene expression using RT-qPCR, for global gene expression using RNA-seq, and for metabolites using gas chromatography-mass spectrometry (GC–MS). The experiment did not reveal any significant effect of the SNP on the expression levels or splicing patterns of LRIG1 or SLC25A26. The global gene expression analysis revealed that the risk allele C was associated with upregulation of several mitochondrial genes. Gene enrichment analysis of 74 differentially expressed genes in the genome revealed a significant enrichment of type I interferon response genes, where many genes were downregulated for the risk allele C. Gene expression data of IDH1 mutated LGGs from the cancer genome atlas (TCGA) revealed a similar under expression of type I interferon genes associated with the risk allele. This study found the expression levels and splicing patterns of LRIG1 and SLC25A26 were not affected by the SNP in HEK293T cells. However, the risk allele was associated with a downregulation of genes involved in the innate immune response both in the HEK293T cells and in the LGG data from TCGA.
format Online
Article
Text
id pubmed-10130147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101301472023-04-27 Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines Rosenbaum, Adam Dahlin, Anna M. Andersson, Ulrika Björkblom, Benny Wu, Wendy Yi-Ying Hedman, Håkan Wibom, Carl Melin, Beatrice Sci Rep Article Genome-wide association studies (GWAS) have contributed to our understanding of glioma susceptibility. To date, 25 risk loci for development of any of the glioma subtypes are known. However, GWAS studies reveal little about the molecular processes that lead to increased risk, especially for non-coding single nucleotide polymorphisms (SNP). A particular SNP in intron 2 of LRIG1, rs11706832, has been shown to increase the susceptibility for IDH1 mutated low-grade gliomas (LGG). Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is important in cancer development as it negatively regulates the epidermal growth factor receptor (EGFR); however, the mechanism responsible for this particular risk SNP and its potential effect on LRIG1 are not known. Using CRISPR-CAS9, we edited rs11706832 in HEK293T cells. Four HEK293T clones with the risk allele were compared to four clones with the non-risk allele for LRIG1 and SLC25A26 gene expression using RT-qPCR, for global gene expression using RNA-seq, and for metabolites using gas chromatography-mass spectrometry (GC–MS). The experiment did not reveal any significant effect of the SNP on the expression levels or splicing patterns of LRIG1 or SLC25A26. The global gene expression analysis revealed that the risk allele C was associated with upregulation of several mitochondrial genes. Gene enrichment analysis of 74 differentially expressed genes in the genome revealed a significant enrichment of type I interferon response genes, where many genes were downregulated for the risk allele C. Gene expression data of IDH1 mutated LGGs from the cancer genome atlas (TCGA) revealed a similar under expression of type I interferon genes associated with the risk allele. This study found the expression levels and splicing patterns of LRIG1 and SLC25A26 were not affected by the SNP in HEK293T cells. However, the risk allele was associated with a downregulation of genes involved in the innate immune response both in the HEK293T cells and in the LGG data from TCGA. Nature Publishing Group UK 2023-04-25 /pmc/articles/PMC10130147/ /pubmed/37185361 http://dx.doi.org/10.1038/s41598-023-33923-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Rosenbaum, Adam
Dahlin, Anna M.
Andersson, Ulrika
Björkblom, Benny
Wu, Wendy Yi-Ying
Hedman, Håkan
Wibom, Carl
Melin, Beatrice
Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title_full Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title_fullStr Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title_full_unstemmed Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title_short Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines
title_sort low-grade glioma risk snp rs11706832 is associated with type i interferon response pathway genes in cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130147/
https://www.ncbi.nlm.nih.gov/pubmed/37185361
http://dx.doi.org/10.1038/s41598-023-33923-4
work_keys_str_mv AT rosenbaumadam lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT dahlinannam lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT anderssonulrika lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT bjorkblombenny lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT wuwendyyiying lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT hedmanhakan lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT wibomcarl lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines
AT melinbeatrice lowgradegliomarisksnprs11706832isassociatedwithtypeiinterferonresponsepathwaygenesincelllines